Scopus Biopharma Inc (SCPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,661 | -26,953 | -20,435 | -19,034 | -3,405 |
| Depreciation Amortization | 1 | 2 | 607 | 520 | 0 |
| Other Working Capital | 588 | 2,841 | 759 | 647 | 165 |
| Other Operating Activity | 95 | 12,686 | 11,792 | 13,108 | 443 |
| Operating Cash Flow | $-3,978 | $-11,425 | $-7,276 | $-4,759 | $-2,797 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -2 | -2 | N/A | N/A |
| Investing Cash Flow | $-2 | $-2 | $-2 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -105 | -105 | N/A | N/A |
| Common Stock Issued | N/A | 20,100 | 10,350 | 10,350 | 10,350 |
| Other Financing Activity | 0 | -2,439 | -1,169 | -1,169 | -1,150 |
| Financing Cash Flow | $0 | $17,557 | $9,077 | $9,181 | $9,200 |
| Exchange Rate Effect | 11 | -19 | 1 | 7 | 20 |
| Beginning Cash Position | 7,943 | 1,832 | 1,832 | 1,832 | 1,832 |
| End Cash Position | 3,975 | 7,943 | 3,632 | 6,261 | 8,256 |
| Net Cash Flow | $-3,968 | $6,111 | $1,800 | $4,429 | $6,424 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,978 | -11,425 | -7,276 | -4,759 | -2,797 |
| Capital Expenditure | -2 | -2 | -2 | N/A | N/A |
| Free Cash Flow | -3,979 | -11,427 | -7,278 | -4,759 | -2,797 |